Useful aspects of submitted secondary pharmacology data. Detailed aspects of secondary pharmacology data that are considered to be useful during regulatory safety assessments are summarized in Table 1 ...

This policy applies to activities that involve the secondary analysis of data (such as medical records, student records, data collected from previous studies, audio/video recordings, etc.) or ...